Free tool
Rare disease stocks
We cover 5 companies grouped under the Rare disease theme. The median market value in the group is $619.77M. Across the group, the median move over the past trading day is +2.88%. Price change over the past year runs from −40.9% to +253.0% across the middle 80 percent of the group, with a median of +60.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 268 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| DBV.PA | DBV Technologies S.A. | $901.25M | Small cap | +60.13% |
| GNFT.PA | Genfit S.A. | $830.56M | Small cap | +310.45% |
| AYJ.DE | Valneva SE | $619.77M | Small cap | −21.89% |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% |
| CRNO-B.ST | Cereno Scientific AB (publ) | $148.23M | Small cap | −53.59% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.